Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Wang, Qinhao"" wg kryterium: Autor


Wyświetlanie 1-18 z 18
Tytuł:
MIIP downregulation drives colorectal cancer progression through inducing peri-cancerous adipose tissue browning.
Autorzy:
Wang, Qinhao (AUTHOR)
Su, Yuanyuan (AUTHOR)
Sun, Ruiqi (AUTHOR)
Xiong, Xin (AUTHOR)
Guo, Kai (AUTHOR)
Wei, Mengying (AUTHOR)
Yang, Guodong (AUTHOR)
Ru, Yi (AUTHOR)
Zhang, Zhengxiang (AUTHOR)
Li, Jing (AUTHOR)
Zhang, Jing (AUTHOR)
Qiao, Qing (AUTHOR)
Li, Xia (AUTHOR)
Pokaż więcej
Źródło:
Cell & Bioscience. 1/20/2024, Vol. 14 Issue 1, p1-22. 22p.
Czasopismo naukowe
Tytuł:
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.
Autorzy:
Li X; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, The Fourth Military Medical University, Xi'an, China.
Liu Y; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Granberg KJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Signal Processing, Tampere University of Technology, Tampere, Finland.; Department of Pathology, Fimlab Laboratories and University of Tampere, Tampere, Finland.
Wang Q; Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, The Fourth Military Medical University, Xi'an, China.
Moore LM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ji P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gumin J; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sulman EP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Calin GA; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Non-coding RNA center, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Haapasalo H; Department of Pathology, Fimlab Laboratories and University of Tampere, Tampere, Finland.
Nykter M; Department of Signal Processing, Tampere University of Technology, Tampere, Finland.; Institute of Biomedical Technology, University of Tampere, Tampere, Finland.
Shmulevich I; Institute for Systems Biology, Seattle, Washington, USA.
Fuller GN; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lang FF; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zhang W; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Non-coding RNA center, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Oncogene [Oncogene] 2015 Mar 26; Vol. 34 (13), pp. 1619-1628. Date of Electronic Publication: 2014 Apr 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genes, Tumor Suppressor*
Brain Neoplasms/*pathology
Glioblastoma/*pathology
MicroRNAs/*physiology
Animals ; Cell Line, Tumor ; Cyclin-Dependent Kinase 6/analysis ; ErbB Receptors/analysis ; Gene Expression Regulation, Neoplastic ; Humans ; Insulin-Like Growth Factor Binding Protein 2/analysis ; Male ; Mice ; MicroRNAs/analysis ; MicroRNAs/genetics ; Neoplasm Invasiveness ; bcl-X Protein/analysis
Czasopismo naukowe
    Wyświetlanie 1-18 z 18

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies